STAT Plus: Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments
weight loss
Ozempic. Wegovy. Mounjaro. There’s a host of game-changing drugs changing the weight-loss industry landscape, and STAT has you covered. From devices such as Fitbit to surgical procedures such as gastric bypass and lap-band surgery, here’s the latest news on obesity efforts.
Latest
STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study
STAT Plus: Ozempic cut risk of death in diabetes patients with chronic kidney disease
STAT Plus: Bernie Sanders may have reached the limits of his pharma pressure campaign
Physicians are deeply divided on a new food-draining weight-loss device
FDA approves weight-loss device that drains out undigested food
In treating obese patients, too often doctors can’t see past weight
